{"id":397,"date":"2025-10-29T04:28:34","date_gmt":"2025-10-29T04:28:34","guid":{"rendered":"https:\/\/cninmed.com\/en\/?p=397"},"modified":"2025-10-29T05:41:09","modified_gmt":"2025-10-29T05:41:09","slug":"china-bd-2025-qyuns-therapeutics-and-ollin-entered-a-107-usd-million-license-for-tslp-il-33-bispecific-antibody-oln324","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2025\/397.html","title":{"rendered":"[China BD 2025] Qyuns Therapeutics and Roche Entered a 107 Million USD License for TSLP\/IL-33 Bispecific Antibody QX031N"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Announced Date: 2025-10-28 (October 28, 2025)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Name: QX031N<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensor (Seller): Qyuns Therapeutics (China)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensee (Buyer): \u00a0Roche<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Modality: Bispecific antibody (BsAb)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Target: TSLP\/IL-33<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Potential Indication: Asthma and COPD<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Current Stage: IND Enabling<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Scope of Authority: <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Qyuns Therapeutics grants Roche the global exclusive right to develop, manufacture, and commercialize QX031N.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Payment Detail: <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Qyuns Therapeutics\u00a0will receive:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">upfront payment of US$75 million,<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">up to US$995 million milestone payments,<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">tiered royalties on potential future product sales<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Link:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.qyuns.net\/upload\/en\/file\/2025-10\/col274\/1761646578139.pdf\">1761646578139.pdf (qyuns.net)<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Note:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Chinese Name of Qyuns Therapeutics, \u8343\u4fe1\u751f\u7269<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announced Date: 2025-10-28 (October 28, 2025) Asset Name: QX031N Licensor (Seller): Qyuns Therapeutics (China) Licensee (Buyer): &hellip; <a title=\"[China BD 2025] Qyuns Therapeutics and Roche Entered a 107 Million USD License for TSLP\/IL-33 Bispecific Antibody QX031N\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2025\/397.html\"><span class=\"screen-reader-text\">[China BD 2025] Qyuns Therapeutics and Roche Entered a 107 Million USD License for TSLP\/IL-33 Bispecific Antibody QX031N<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-397","post","type-post","status-publish","format-standard","hentry","category-china-license-out"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=397"}],"version-history":[{"count":3,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/397\/revisions"}],"predecessor-version":[{"id":401,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/397\/revisions\/401"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}